Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
ADC touts early Zynlonta results in marginal zone lymphoma
ADC Therapeutics provided several updates Monday, including that it's raising $105 million through a sale of common shares and pre-funded warrants.
Eric Sagonowsky
May 6, 2024 4:19pm
Regulatory tracker: FDA accepts BMS' subQ application for Opdivo
May 6, 2024 3:05pm
Sponsored
Ensuring your HCP engagement model is up to task as brands mature
May 6, 2024 8:00am
Pfizer hires analyst Andrew Baum to manage portfolio strategy
May 6, 2024 11:09am
Sponsored
MAIC Methodology Matters: Comparing BRUKINSA vs Acalabrutinib in R/R CLL
Apr 1, 2024 8:00am
Amneal resolves opioid lawsuits with $272.5M settlement
May 6, 2024 11:00am